Search the website | European Medicines Agency

Search the website

Use this page to find content on this website. For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Date of opinion

PIP decision type

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

PIP compliance check

Compliance procedure number

Medicine type

Related medicine

Therapeutic area

Topic

Last updated

First published

1 results

Sort by

List item

Opinion/decision on a Paediatric investigation plan (PIP): Tysabri, natalizumab

Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Neurology
PIP number: EMEA-001095-PIP02-12, Route(s) of administration: Intravenous use, Pharmaceutical form(s): Concentrate for solution for infusion
Decision date: 19/10/2012, Last updated: 27/11/2012, Compliance check: V, 16/12/2016